Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994

Journal of Infectious Diseases

Volumn 176, Issue 2, 1997, Pages 456-463

  Guris, Dalya ^a,b   Strebel, Peter M ^a   Tachdjian, Raffi ^a   Bardenheier, Barbara ^a   Wharton, Melinda ^a   Hadler, Stephen C ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b MS E 61 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ARTICLE; BACTERIUM CULTURE; CHILD; DOSE RESPONSE; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRIORITY JOURNAL; SCREENING; VACCINATION;

EID: 0030753967     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514064     Document Type: Article

References (29)

1. Farizo KM, Cochi SL, Zell ER, Patriarca PA, Wassilak SGF, Brink E. Epidemiologic features of pertussis in the United States, 1980-1989. Clin Infect Dis 1992;14:708-19.
2. Davis SF, Strebel PM, Cochi SL, Zell ER, Hadler SC. Pertussis surveillance-United States, 1989-1991. MMWR Morb Mortal Wkly Rep 1992;41(SS-8):11-9.
3. Centers for Disease Control and Prevention. Resurgence of pertussis - United States, 1993. MMWR Morb Mortal Wkly Rep 1993;42:952-3, 959-60.
4. Christie CDC, Marx ML, Marchant CD, Reising SF. The 1993 epidemic of pertussis in Cincinnati - resurgence of disease in a highly immunized population of children. N Engl J Med 1994;331:16-21.
5. Kenyon TA, Izurieta H, Shulman ST, et al. Large outbreak of pertussis among young children in Chicago, 1993: investigation of potential contributing factors and estimation of vaccine effectiveness. Pediatr Infect Dis J 1996;15:655-61.
6. Izurieta HS, Kenyon TA, Strebel PM, Baughman AL, Shulman ST, Wharton M. Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin Infect Dis 1996;22:503-7.
7. Centers for Disease Control and Prevention. Vaccination coverage of 2-year-old children-United States, 1993. MMWR Morb Mortal Wkly Rep 1994;43:705-9.
8. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage levels among children aged 19-35 months - United States, April 1994-March 1995. MMWR Morb Mortal Wkly Rep 1996;45:145-50.
9. Onorato IM, Wassilak SG, Meade B. Efficacy of whole-cell pertussis vaccine in preschool children in the United States. JAMA 1992;267:2745-9.
10. Centers for Disease Control and Prevention. Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use - supplementary ACIP statement: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1992;41(RR-1):1-10.
11. Centers for Disease Control and Prevention. Pertussis vaccination: acellular pertussis vaccine for the fourth and fifth doses of the DTP series, update to supplementary ACIP statement: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1992;41(RR-15):1-5.
12. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996;334:341-8.
13. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996;334:349-55.
14. Schmitt HJ, Wirsing von Konig CH, Neiss A, et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 1996;275:37-41.
15. Proceedings of pertussis conference. Washington, DC: National Institutes of Health, 3-5 June 1996.
16. Massey JT, Moore TF, Parsons VL, Tadros W. Design and estimation for the National Health Interview Survey, 1985-94. Hyattsville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, 1989; Vital and Health Statistics, series 2, no. 110.
17. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Epidemiol Rev 1988;10:212-41.
18. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993;22:742-6.
19. Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985;41:55-68.
20. Centers for Disease Control and Prevention. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep 1990;39(RR-13):26-7.
21. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
22. Ramsay MEB, Farrington CP, Miller E. Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol Infect 1993;111:41-8.
23. Centers for Disease Control and Prevention. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997:46(RR-7):1-25.
24. Miller CL, Fletcher WB. Severity of notified whooping cough. Br Med J 1976;1:117-9.
25. Grob PR, Crowder MJ, Robbins JF. Effect of vaccination on severity and dissemination of whooping cough. Br Med J 1981;282:1925-8.
26. Royal College of General Practitioners Swansea Research Unit. Effect of a low pertussis vaccination uptake on a large community. Br Med J 1981;282:23-6.
27. Public Health Laboratory Service. Efficacy of pertussis vaccination in England. Br Med J 1982;285:357-9.
28. Hardy IR, Hoekstra E, Wells V, et al. Large pertussis outbreak, Cincinnati, 1993: high attack rate among vaccinated preschool children [abstract J-71]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, FL). Washington, DC: American Society for Microbiology, 1994:79.
29. Sutler RW, Cochi SL. Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. JAMA 1992;267:386-91.